全般性不安障害の世界市場レポート 2025年

全般性不安障害の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR3.9％で93億2,000万米ドルに成長します。予測期間の成長は、デジタルメンタルヘルスソリューション、遺伝子調査、統合ケアモデル、世界のメンタルヘルス意識に起因しています。予測期間の主な動向には、全体論的アプローチ、文化的能力、早期介入、診断における人工知能（AI）などがあります。

ヘルスケア業界における精神障害の有病率の増加が全般性不安障害市場の拡大に拍車をかけています。精神障害は精神疾患としても知られ、人の思考、感情、行動、全体的な精神的健康に影響を与えるさまざまな状態を包括しています。全般性不安障害によく関連する疾患には、恐怖症、パニック障害、心的外傷後ストレス障害（PTSD）、強迫性障害（OCD）などがあり、これらの状態を管理することは、個人が健全な人間関係を維持し、生活の質を高めるために不可欠です。例えば、2023年11月に米国心理学会が実施した*ストレス・イン・アメリカ2023*調査では、35歳から44歳の成人が精神疾患の診断において最大の増加を示し、2023年には31％から45％が精神疾患を報告したと報告されています。一方、18歳から34歳の成人は引き続き精神疾患の割合が最も高く、2023年には50％が診断を受けたと報告しています。このように、精神疾患患者数の増加が全般性不安障害市場の成長を促進すると予測されています。

政府のイニシアチブの拡大が全般性不安障害市場の成長を促進しています。政府の取り組みには、特定の問題や課題に対処するために政府当局が実施する戦略的な計画や行動が含まれ、多くの場合、税金、助成金、寄付金などのさまざまな手段によって資金が調達されます。全般性不安障害（GAD）の文脈では、これらのイニシアチブは、GADの原因や治療方法の理解を深めることを目的とした研究開発、およびこの症状に対処する個人を支援するための革新的でより効果的なアプローチを開発するための研究開発に資金を提供することにより、極めて重要な役割を果たしています。例えば、2022年3月、米国を拠点とする必要不可欠な福祉サービスの提供者である保健福祉省（HHS）は、米国全土の子どもや若者のための地域精神保健サービスや自殺予防プログラムを強化・拡大するため、総額約3,500万米ドルの資金提供の機会を発表しました。その結果、政府のイニシアチブの高まりが全般性不安障害市場の成長を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界全般性不安障害 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の全般性不安障害市場：成長率分析
• 世界の全般性不安障害市場の実績：規模と成長, 2019-2024
• 世界の全般性不安障害市場の予測：規模と成長, 2024-2029, 2034F
• 世界全般性不安障害総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の全般性不安障害市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• パニック障害
• 広場恐怖症
• 全般性不安障害
• 社会不安
• 特定の恐怖症
• その他のタイプ
• 世界の全般性不安障害市場治療法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 対人関係療法
• 行動療法
• 認知行動療法
• マインドフルネスに基づく認知療法
• 世界の全般性不安障害市場：デバイス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脳深部刺激療法
• 電気けいれん療法
• 経頭蓋磁気刺激
• 迷走神経刺激
• 世界の全般性不安障害市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• ホームケア
• 専門クリニック
• その他のエンドユーザー
• 世界の全般性不安障害市場パニック障害のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 再発性パニック発作
• 予期せぬパニック発作
• 世界の全般性不安障害市場広場恐怖症の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 状況恐怖症
• オープンスペースの不安
• 世界の全般性不安障害市場全般性不安障害のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 慢性的な心配
• 過度の不安
• 世界の全般性不安障害市場、社会不安障害のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• パフォーマンス不安
• 対人関係不安
• 世界の全般性不安障害市場、特定の恐怖症の種類別の細分化、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物恐怖症
• 環境恐怖症
• 状況恐怖症
• 世界の全般性不安障害市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 分離不安障害
• 選択性緘黙症
• 心的外傷後ストレス障害（PTSD）

第7章 地域別・国別分析

• 世界の全般性不安障害市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の全般性不安障害市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 全般性不安障害市場：競合情勢
• 全般性不安障害市場：企業プロファイル
  • Alkermes plc Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GlaxoSmithKline plc
• AstraZeneca plc
• Abbott Laboratories
• 3M Company
• Boehringer Ingelheim International GmbH
• Johnson And Johnson Private Limited
• Adobe Inc.
• Baxter International Inc.
• Teva Pharmaceutical Industries Ltd.
• Otsuka Holdings Co. Ltd.
• Mylan N.V.
• Sumitomo Pharma Co. Ltd.
• Jazz Pharmaceuticals plc
• Forest Laboratories Inc.
• H. Lundbeck A/S

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 全般性不安障害市場2029：新たな機会を提供する国
• 全般性不安障害市場2029：新たな機会を提供するセグメント
• 全般性不安障害市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Generalized anxiety disorder (GAD) is a mental health condition distinguished by the presence of excessive and persistent worry, fear, and anxiety that encompass various facets of life. These concerns span a wide spectrum and can often become uncontrollable and overwhelming. The choice of treatment depends on the extent to which GAD impairs an individual's ability to function in their daily life.

The generalized anxiety disorder can manifest in various forms, including panic disorder, agoraphobia, generalized anxiety, social anxiety, specific phobia, and other variations. Panic disorder characterizes a mental health condition marked by recurring and unexpected episodes of intense fear and discomfort, known as panic attacks. These conditions can be effectively addressed through a range of therapeutic approaches, such as interpersonal therapy, behavior therapy, cognitive behavioral therapy, and mindfulness-based cognitive therapy, and can involve the use of diverse medical devices, including deep brain stimulation, electroconvulsive therapy, transcranial magnetic stimulation, and vagus nerve stimulation. These treatments are administered in diverse healthcare settings, including hospitals, home care, specialty clinics, and other healthcare facilities.

The generalized anxiety disorder market research report is one of a series of new reports from The Business Research Company that provides generalized anxiety disorder market statistics, including generalized anxiety disorder industry global market size, regional shares, competitors with a generalized anxiety disorder market share, detailed generalized anxiety disorder market segments, market trends and opportunities and any further data you may need to thrive in the generalized anxiety disorder industry. This generalized anxiety disorder market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The generalized anxiety disorder market size has grown steadily in recent years. It will grow from $7.76 billion in 2024 to $8.01 billion in 2025 at a compound annual growth rate (CAGR) of 3.2%. The growth in the historic period can be attributed to mental health awareness, pharmaceutical advances, cognitive-behavioral therapy (cbt), stressful lifestyle changes.

The generalized anxiety disorder market size is expected to see steady growth in the next few years. It will grow to $9.32 billion in 2029 at a compound annual growth rate (CAGR) of 3.9%. The growth in the forecast period can be attributed to digital mental health solutions, genetic research, integrated care models, global mental health awareness. Major trends in the forecast period include holistic approaches, cultural competence, early intervention, artificial intelligence (AI) in diagnosis.

The increasing prevalence of mental disorders within the healthcare industry is fueling the expansion of the generalized anxiety disorder market. Mental disorders, also known as mental illnesses, encompass a variety of conditions that impact a person's thoughts, emotions, behaviors, and overall mental health. Disorders commonly associated with generalized anxiety disorder include phobias, panic disorder, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD), and managing these conditions is essential for individuals to sustain healthy relationships and enhance their quality of life. For example, in November 2023, the American Psychological Association's *Stress in America 2023* survey reported that adults aged 35 to 44 showed the largest increase in mental health diagnoses, with 45% reporting a mental illness in 2023, up from 31%. Meanwhile, adults aged 18 to 34 continued to have the highest rate of mental illnesses, with 50% reporting a diagnosis in 2023. Thus, the rising number of mental disorder cases is anticipated to drive growth in the generalized anxiety disorder market.

The expansion of government initiatives is propelling the growth of the generalized anxiety disorder market. Government initiatives encompass strategic plans or actions undertaken by governmental authorities to address specific problems or issues, often financed through various means, including taxes, grants, and donations. Within the context of generalized anxiety disorder (GAD), these initiatives play a pivotal role by funding research aimed at enhancing the understanding of GAD's causes and treatment methods, as well as developing innovative and more effective approaches to assist individuals dealing with this condition. For example, in March 2022, the Department of Health and Human Services (HHS), a US-based provider of essential human services, announced funding opportunities totaling nearly $35 million to enhance and expand community mental health services and suicide prevention programs for children and young people across the United States. Consequently, the growing government initiatives are expected to drive the growth of the generalized anxiety disorder market.

Key players in the generalized anxiety disorder market are actively engaged in the development of innovative medications, such as MM-120, and securing approvals for the treatment of generalized anxiety disorder, thus better catering to the needs of their existing clientele. Innovative drugs like MM-120 aim to enhance the management and outcomes of this mental health condition. For example, in January 2022, Mind Medicine Inc., a US-based biotech company specializing in psychedelic medicine, obtained approval for an Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA). This milestone enables the company to advance its phase IIb dose-optimization trial of MM-120 for the treatment of generalized anxiety disorder (GAD). MM-120 is a small molecule acting as a partial agonist of the 5-HT2A receptor, which plays a role in mood regulation, anxiety, and perception. Furthermore, MM-120 is believed to function by elevating serotonin levels in the brain, opening the door for the development of other psychedelic compounds to address mental health disorders.

In July 2023, Big Health, a US-based digital therapeutics company, successfully acquired Limbix Health Inc. for an undisclosed sum. This strategic move by Big Health is aimed at uniting the strengths and resources of both companies to advance the development and delivery of more effective digital therapeutics for mental health conditions. Limbix Health Inc. is a US-based digital therapeutics platform that provides mental health treatment for young individuals dealing with depression, anxiety, and other mental health ailments.

Major companies operating in the generalized anxiety disorder market are Alkermes PLC, Pfizer Inc., F. Hoffmann-La Roche AG, Sanofi SA, Bristol-Myers Squibb, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, 3M Company, Boehringer Ingelheim International GmbH, Johnson And Johnson Private Limited, Adobe Inc., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Otsuka Holdings Co. Ltd., Mylan N.V., Sumitomo Pharma Co. Ltd., Jazz Pharmaceuticals PLC, Forest Laboratories Inc., H. Lundbeck A/S, Shionogi and Company, Neurocrine Biosciences Inc., Actavis Pharmaceutical Company, Eli Lilly and Company, Noven Pharmaceuticals Inc., Mind Medicine Inc., Sage Therapeutics Inc., Bionomics Ltd., Recordati Rare Diseases SARL, VistaGen Therapeutics Inc.

North America was the largest region in the generalized anxiety disorder market in 2024. The regions covered in generalized anxiety disorder report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the generalized anxiety disorder market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generalized anxiety disorder market consists of revenues earned by entities by providing services such as exposure therapy, supportive psychotherapy, relaxation therapies, group therapy, stress management and self-care practices. The market value includes the value of related goods sold by the service provider or included within the service offering. The generalized anxiety disorder market also includes sales of pregabalin, hydroxyzine, beta-blockers, atypical antipsychotics and alprazolam. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generalized Anxiety Disorder Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generalized anxiety disorder market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generalized anxiety disorder ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The generalized anxiety disorder market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Panic Disorder; Agoraphobia; Generalized Anxiety; Social Anxiety; Specific Phobia; Other Types
• 2) By Therapies: Interpersonal Therapy; Behavior Therapy; Cognitive Behavioral Therapy; Mindfulness Based Cognitive Therapy
• 3) By Device: Deep Brain Stimulation; Electroconvulsive Therapy; Transcranial Magnetic Stimulation; Vagus Nerve Stimulation
• 4) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Panic Disorder: Recurrent Panic Attacks; Unexpected Panic Attacks
• 2) By Agoraphobia: Situational Phobia; Open Spaces Anxiety
• 3) By Generalized Anxiety: Chronic Worry; Excessive Anxiety
• 4) By Social Anxiety: Performance Anxiety; Interaction Anxiety
• 5) By Specific Phobia: Animal Phobia; Environmental Phobia; Situational Phobia
• 6) Other Type: Separation Anxiety Disorder; Selective Mutism; Post-Traumatic Stress Disorder (PTSD)
• Companies Mentioned: Alkermes plc; Pfizer Inc.; F. Hoffmann-La Roche AG; Sanofi SA; Bristol-Myers Squibb
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Generalized Anxiety Disorder Market Characteristics

3. Generalized Anxiety Disorder Market Trends And Strategies

4. Generalized Anxiety Disorder Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Generalized Anxiety Disorder Growth Analysis And Strategic Analysis Framework

• 5.1. Global Generalized Anxiety Disorder PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Generalized Anxiety Disorder Market Growth Rate Analysis
• 5.4. Global Generalized Anxiety Disorder Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Generalized Anxiety Disorder Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Generalized Anxiety Disorder Total Addressable Market (TAM)

6. Generalized Anxiety Disorder Market Segmentation

• 6.1. Global Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Panic Disorder
• Agoraphobia
• Generalized Anxiety
• Social Anxiety
• Specific Phobia
• Other Types
• 6.2. Global Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Interpersonal Therapy
• Behavior Therapy
• Cognitive Behavioral Therapy
• Mindfulness Based Cognitive Therapy
• 6.3. Global Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Deep Brain Stimulation
• Electroconvulsive Therapy
• Transcranial Magnetic Stimulation
• Vagus Nerve Stimulation
• 6.4. Global Generalized Anxiety Disorder Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End-Users
• 6.5. Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Panic Disorder, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Recurrent Panic Attacks
• Unexpected Panic Attacks
• 6.6. Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Agoraphobia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Situational Phobia
• Open Spaces Anxiety
• 6.7. Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Generalized Anxiety, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Worry
• Excessive Anxiety
• 6.8. Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Social Anxiety, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Performance Anxiety
• Interaction Anxiety
• 6.9. Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Specific Phobia, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Animal Phobia
• Environmental Phobia
• Situational Phobia
• 6.10. Global Generalized Anxiety Disorder Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Separation Anxiety Disorder
• Selective Mutism
• Post-Traumatic Stress Disorder (PTSD)

7. Generalized Anxiety Disorder Market Regional And Country Analysis

• 7.1. Global Generalized Anxiety Disorder Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Generalized Anxiety Disorder Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Generalized Anxiety Disorder Market

• 8.1. Asia-Pacific Generalized Anxiety Disorder Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Generalized Anxiety Disorder Market

• 9.1. China Generalized Anxiety Disorder Market Overview
• 9.2. China Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Generalized Anxiety Disorder Market

• 10.1. India Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Generalized Anxiety Disorder Market

• 11.1. Japan Generalized Anxiety Disorder Market Overview
• 11.2. Japan Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Generalized Anxiety Disorder Market

• 12.1. Australia Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Generalized Anxiety Disorder Market

• 13.1. Indonesia Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Generalized Anxiety Disorder Market

• 14.1. South Korea Generalized Anxiety Disorder Market Overview
• 14.2. South Korea Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Generalized Anxiety Disorder Market

• 15.1. Western Europe Generalized Anxiety Disorder Market Overview
• 15.2. Western Europe Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Generalized Anxiety Disorder Market

• 16.1. UK Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Generalized Anxiety Disorder Market

• 17.1. Germany Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Generalized Anxiety Disorder Market

• 18.1. France Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Generalized Anxiety Disorder Market

• 19.1. Italy Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Generalized Anxiety Disorder Market

• 20.1. Spain Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Generalized Anxiety Disorder Market

• 21.1. Eastern Europe Generalized Anxiety Disorder Market Overview
• 21.2. Eastern Europe Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Generalized Anxiety Disorder Market

• 22.1. Russia Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Generalized Anxiety Disorder Market

• 23.1. North America Generalized Anxiety Disorder Market Overview
• 23.2. North America Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Generalized Anxiety Disorder Market

• 24.1. USA Generalized Anxiety Disorder Market Overview
• 24.2. USA Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Generalized Anxiety Disorder Market

• 25.1. Canada Generalized Anxiety Disorder Market Overview
• 25.2. Canada Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Generalized Anxiety Disorder Market

• 26.1. South America Generalized Anxiety Disorder Market Overview
• 26.2. South America Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Generalized Anxiety Disorder Market

• 27.1. Brazil Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Generalized Anxiety Disorder Market

• 28.1. Middle East Generalized Anxiety Disorder Market Overview
• 28.2. Middle East Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Generalized Anxiety Disorder Market

• 29.1. Africa Generalized Anxiety Disorder Market Overview
• 29.2. Africa Generalized Anxiety Disorder Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Generalized Anxiety Disorder Market, Segmentation By Therapies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Generalized Anxiety Disorder Market, Segmentation By Device, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Generalized Anxiety Disorder Market Competitive Landscape And Company Profiles

• 30.1. Generalized Anxiety Disorder Market Competitive Landscape
• 30.2. Generalized Anxiety Disorder Market Company Profiles
  • 30.2.1. Alkermes plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

31. Generalized Anxiety Disorder Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline plc
• 31.2. AstraZeneca plc
• 31.3. Abbott Laboratories
• 31.4. 3M Company
• 31.5. Boehringer Ingelheim International GmbH
• 31.6. Johnson And Johnson Private Limited
• 31.7. Adobe Inc.
• 31.8. Baxter International Inc.
• 31.9. Teva Pharmaceutical Industries Ltd.
• 31.10. Otsuka Holdings Co. Ltd.
• 31.11. Mylan N.V.
• 31.12. Sumitomo Pharma Co. Ltd.
• 31.13. Jazz Pharmaceuticals plc
• 31.14. Forest Laboratories Inc.
• 31.15. H. Lundbeck A/S

32. Global Generalized Anxiety Disorder Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Generalized Anxiety Disorder Market

34. Recent Developments In The Generalized Anxiety Disorder Market

35. Generalized Anxiety Disorder Market High Potential Countries, Segments and Strategies

• 35.1 Generalized Anxiety Disorder Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Generalized Anxiety Disorder Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Generalized Anxiety Disorder Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer